R15-2017-e
Strengthening paediatric TB services for enhanced early detection (TB SPEED)
R14-2017-e
IMPAACT4TB Increasing market and public health outcomes through scaling up affordable access models of short course preventive therapy for TB
R16-2017-e
Indemnification of WHO with respect to claims under a Bank of England Mandate Letter
R11-2017-e
Costed extension of the ACCESS-SMC project
R12-2017-e
No cost extension of the Project “Market entry of an improved solid protease inhibitor-based first line antiretroviral combination therapy for infants and young children with HIV/AIDS” by DNDi
R13-2017-e
Amended Calendar of Board and Committee meetings dates for the fourth quarter of 2017
R7-2017-e
Preparedness for the rollout of effective HIV prevention among Key affected Populations in Brazil, Peru and Mexico
R6-2017-e
Costed extension of Unitaid project support to WHO Prequalification of Medicines and Diagnostics
